Outcomes measured with standardized baseline and 6-month follow-up assessments on validated scales. See our full outcomes methodology →
The Veterans' Crisis
Why VA Treatments Fail Veterans with PTSD
Twenty-two veterans die by suicide every day. The VA has invested heavily in SSRI pharmacotherapy and evidence-based talk therapies — and for a portion of veterans, these approaches provide meaningful relief. But a substantial cohort remains treatment-resistant: still experiencing flashbacks, hypervigilance, emotional numbness, and the relentless intrusion of combat memory despite years of medication management and multiple inpatient stays. SSRIs manage symptoms at the neurotransmitter level — they do not address traumatic memory consolidation, disrupted fear extinction circuits, or the chronic neuroinflammation that PTSD and TBI produce at the structural level of the brain.
Ibogaine works at the architectural level. GDNF upregulation repairs damaged neural circuits. Multi-receptor reset — serotonin, dopamine, opioid, NMDA, sigma-2 — simultaneously addresses the neurochemical disruption that combat trauma produces. Deep introspective processing enables veterans to confront and resolve traumatic memories in a state that feels observational rather than reactive. This is not symptom management. It is structural repair at the level where the damage actually lives.
Veterans carry burdens that are qualitatively distinct from civilian trauma. Moral injury — guilt, shame, and identity disruption from actions taken or witnessed in service — compounds combat PTSD in ways standard protocols were not designed to address. Blast TBI adds neuroinflammatory damage outside the scope of psychotherapy. Operational tempo means years of consecutive high-stress exposure. And the culture of stoicism that makes effective soldiers often makes it profoundly difficult to engage with conventional mental health treatment. Ibogaine's single-session depth addresses what years of talk therapy cannot.
$750 Veteran & First Responder Discount
Active duty military, veterans, National Guard, reservists, and first responders — police, fire, EMS, paramedics — receive $750 off any MindScape treatment program. This discount applies to all programs ranging from $7,500 to $15,500.
Present valid military ID, DD-214, veteran health card, or first responder credentials during intake. The discount is applied at booking — no codes, no hoops. Medical professionals and government employees qualify too →
What's Included
- All-inclusive accommodation & meals
- Complete medical evaluations
- Ibogaine treatment session
- Supplementary therapies
- 90-day structured aftercare
- Airport transfer from Cancun
Programs Available
- 5-Day Intensive$7,500$6,750
- 7-Day Standard$8,500$7,750
- 10-Day Comprehensive$11,500$10,750
- 14-Day Veteran Protocol$15,500$14,750
Conditions We Treat
PTSD Conditions We Treat in Veterans
Combat PTSD
Flashbacks, hypervigilance, nightmares, emotional numbness. 98.6% PCL-5 resolution at 6 months. Ibogaine facilitates the processing of traumatic memories at the neurological level — transforming active wounds into resolved history.
Blast TBI & Concussion
GDNF upregulation repairs damaged neural circuits. Sigma-2 receptor activation reduces neuroinflammation. Many TBI patients report cognitive clarity and emotional regulation improvements that decades of conventional treatment failed to produce.
Moral Injury
Guilt, shame, identity disruption from actions taken or witnessed in service. Ibogaine's introspective window enables resolution at the psychological depth where moral injury lives — territory that medication cannot reach and talk therapy often cannot safely enter.
Treatment-Resistant PTSD
Failed SSRIs, multiple inpatient stays, years of therapy. Ibogaine addresses the neurological architecture sustaining PTSD — not the symptoms, but the structural disruption producing them. Almost every veteran patient arrives having tried everything else first.
The Research
Stanford, Texas $50M, and Growing Evidence
Stanford Medicine's study of 30 special operations veterans with mild-to-moderate TBI found PTSD symptoms dropped 88% within one month of ibogaine treatment, with 71% of participants no longer meeting diagnostic criteria at one-year follow-up. These findings, published across 2024 and 2025, represent the strongest longitudinal evidence to date for ibogaine's efficacy in combat-related trauma.
Texas Senate Bill 2308 allocated $50 million in state-matching funds for ibogaine clinical trials — the largest publicly funded psychedelic research initiative in American history. UTHealth Houston and UTMB Galveston were awarded the contract in December 2025 to conduct a two-year, multicenter trial enrolling up to 300 participants, primarily veterans and first responders.
The FDA's August 2024 rejection of MDMA-assisted therapy for PTSD redirected attention toward ibogaine's single-session advantage. Unlike MDMA, which requires multiple sessions spanning weeks, ibogaine produces clinically significant outcomes within a single treatment. For treatment-resistant veterans who cannot wait for the regulatory timeline to resolve, ibogaine is available now, medically supervised, with six years of outcome data behind it.
Veteran advocacy is what has moved this politically. In May 2026 DAV, the Disabled American Veterans, announced a partnership with Americans for Ibogaine on research and policy advocacy, and on 30 June 2026 Representative Morgan Luttrell of Texas, a former Navy SEAL, led the introduction of H.R. 9559, which would force a decision on moving ibogaine out of Schedule I. Neither has changed the law yet. We track every federal and state development, with sources and dates, on our ibogaine policy tracker.
Your Journey
Your Veterans Treatment Path
Veterans Intake
Connect with our veterans coordinator — a dedicated team member who understands military culture and service-connected trauma. Share your service history, treatment history, and current challenges in a confidential, judgment-free conversation. No obligation, and no VA or military reporting.
Medical Clearance
Complete cardiac screening including 12-lead EKG, comprehensive bloodwork, and full medication review. Most VA-prescribed psychiatric medications — SSRIs, SNRIs, benzodiazepines, and Z-drugs — do NOT require an at-home taper: you arrive on your current prescribed dose and the taper is performed onsite under continuous physician supervision and telemetry, with twice-daily ibogaine TA (total alkaloid) booster doses bridging serotonergic and GABAergic tone during washout. Pre-arrival contraindications that DO require clearance before arrival: MAOIs (mandatory 2-week washout), tricyclic antidepressants, lithium, methadone (transitioned to a short-acting opioid), and Class III antiarrhythmics. Your specific plan is built during the medical review.
Arrival in Cozumel
Private airport pickup and transfer from Cancun International. Settle into your accommodation, meet the medical team and integration therapists. The first days are dedicated to orientation, final medical assessment, and beginning the TA booster phase that primes your neurochemistry.
Treatment Protocol
A 7-18 day customized ibogaine protocol under continuous 24/7 physician supervision with cardiac monitoring. The TA booster phase spans multiple days before the HCl flood session. Daily integration sessions process what arises. For most veterans, the flood session represents the most significant psychological experience of their lives.
Aftercare & Reintegration
90-day structured integration plan begins at discharge. Scheduled follow-up sessions, access to our veteran peer support community, and a clear framework for translating the neuroplastic window into lasting change. We do not discharge veterans into silence.
Veterans FAQ
Questions From Veterans & First Responders
Explore Related Treatment Resources
Primary References
Our protocols align with the primary scientific literature, including the MAPS Ibogaine Investigator's Brochure (July 2026), NIDA's psychedelic & dissociative drugs research, and registered trials on ClinicalTrials.gov, the VA National Center for PTSD, the 2024 Stanford magnesium-ibogaine study (Nature Medicine). Ibogaine remains investigational; we pair published evidence with measured, real-world outcome tracking.
Measured & safe
Recovery you can track. Safety you can trust.
Our proprietary data system measures your progress before, during, and after your stay, and monitors your safety at every step. The same data that keeps you safe is the data that proves it worked.
Validated instruments build your baseline before you travel.
Cardiac and vital monitoring around your session, read in real time.
Your progress re-scored against your baseline, in your portal.
Every MindScape treatment program includes a guided 5-MeO-DMT (Bufo) ceremony — part of the all-inclusive price, not an add-on.
Precision dosing
Your main dose is measured, not estimated
Before the main session, we give a short series of low, sub-psychoactive ibogaine TA boosters. Each one is a measurement. Ibogaine and its long-lived metabolite noribogaine both affect the heart's hERG potassium channel, and that effect is dose-dependent, so instead of predicting how you will respond we observe it directly at doses far below a full session. Your main dose is then chosen from your own cardiac response and the margin you have left.
No ibogaine given. 12-lead ECG, electrolytes and liver panel establish the starting point. A baseline outside safe limits stops the programme here.
These are the measurements the protocol is built around. The trace above is a schematic used to explain the method; it is not a recording of a patient, and the values shown are illustrative rather than results.
How the booster protocol works for veterans with PTSD →Looking for ibogaine treatment for veterans ptsd accessible from your state? MindScape Retreat treats patients from across the US with direct flights to Cozumel. Find ibogaine treatment near you.